The FDA has approved supplemental applications for Sovaldi (sofosbuvir) and Harvoni (ledipasvir/sofosbuvir) to treat hepatitis C virus (HCV) infection in children 12 to 17 years of age. Harvoni and Sovaldi were previously approved to treat HCV infection in adults. Both products are marketed by Gilead Sciences.

The FDA has issued a complete response letter regarding Merck’s supplemental new drug applications for Januvia (sitagliptin), Janumet (sitagliptin and metformin), and Janumet XR (sitagliptin and metformin extended-release).

In a recent New England Journal of Medicine (NEJM) editorial, Debabrata Mukherjee, MD, chief of cardiovascular medicine and chair of the Department of Internal Medicine at Texas Tech University Health Sciences Center El Paso, commented on bioresorbable stents, an alternative to the traditional stents used in patients with cardiac conditions.

Now it’s official. A couple of days ago we reported on Wellmark Blue Cross and Blue Shield’s decision to exit the ACA exchange in Iowa.

Fosfomycin for injection (Zolyd, Zavante Therapeutics) has met the primary endpoint of statistical noninferiority to piperacillin/tazobactam in a pivotal study of patients with complicated urinary tract infections (UTIs), including acute pyelonephritis (AP).

Congress has left town for a two-week recess without a deal to end House Republicans’ infighting over changes to the Patient Protection and Affordable Care Act (PPACA), thwarting GOP hopes for a quick revival of replacement legislation, according to a Reuters report.

According to a new study from the Urban Institute, hospitals in states that expanded Medicaid under the Patient Protection and Affordable Care Act (PPACA) increased Medicaid revenue, reduced uncompensated care, and improved operating margins in 2015.

Survival rates for several major cancers have steadily improved over the last couple of decades, according to the American Cancer Society (ACS). Still, an annual report estimates that nearly 1.7 million new cancer cases will occur in 2017 in the United States, with close to 700,000 deaths.

Obese adults between the ages of 25 and 64 are at least four times more likely to have been diagnosed with diabetes than are those with a normal weight, according to a new Gallup survey. By their middle to late 30s, 9.3% of adults who are obese have been diagnosed with diabetes compared with 1.8% of those who are normal weight.

First the cold, hard facts: There are none. This is anecdotal.  Those who love burying their heads in academic peer-reviewed articles that are fastidiously sourced might want to stop here.

Now that the GOP effort to dismantle the Patient Protection and Affordable Care Act (PPACA) is in limbo, are there ways to make it work better? “Yes,” says Kaiser Health News columnist Julie Rovner. She offers four possibilities.

Despite a workday filled with “too many rules and regulations” and hours spent on paperwork, nearly eight out of 10 U.S. physicians would choose medicine again as a career, according to the results of the 2017 Medscape Physician Compensation Report.

Few patients pay a hospital’s full price for a procedure or test, but a new study shows why those charges still matter, according to a report from Kaiser Health News.

Women who develop Zika virus infection (ZVI) during pregnancy have a one-in-10 chance of having a fetus or infant with virus-associated birth defects, and this rate can increase to 15% if the infection occurs during the first trimester, according to a report from the Centers for Disease Control and Prevention (CDC).

The first patient in the United States has been treated in a trial assessing the safety and efficacy of a new approach to removing blockages in leg arteries.

Pages